Actively Recruiting
Study Comparing the Need for a Second Bladder Tumor Surgery in High-risk Non-Muscle-Invasive Bladder Cancer Patients Using Urine Biomarker Test After Initial Surgery
Led by The First Affiliated Hospital with Nanjing Medical University · Updated on 2024-03-01
428
Participants Needed
1
Research Sites
82 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating whether a urine biomarker test can help decide if patients with non-muscle-invasive bladder cancer NMIBC need a second surgery called reTURBT after their initial tumor removal. The study aims to find out if patients who test negative for this urine biomarker can safely avoid the second surgery without increasing the risk of cancer returning. This approach could lead to more personalized treatment and reduce unnecessary procedures for NMIBC patients. Participants who have completed their initial TURBT and tested negative for the urine biomarker will be randomly assigned to one of two groups. Group A will not receive the second surgery and will follow standard care guidelines, while Group B will undergo reTURBT followed by standard care. Before reTURBT, participants will provide urine samples for the biomarker test. The study compares the recurrence-free survival RFS rates between the two groups to evaluate the safety of avoiding reTURBT based on the biomarker results. During the study, participants will be monitored for cancer recurrence over two years, with researchers assessing the time from the initial surgery to any confirmed recurrence. Participants will provide urine samples and clinical information throughout the follow-up period. The trial ensures participant confidentiality and follows strict ethical guidelines. The findings may improve clinical decisions and management for patients with high-risk NMIBC by potentially reducing unnecessary surgeries.
CONDITIONS
Brief Title
The Necessity of a Second Transurethral Resection in High-risk Non-muscle-invasive Bladder Cancer Patients With Negative Urine Biomarker After Initial Transurethral Resection
Research Team
Q
Qiang Lv, Ph.D
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here